Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.539,65
0,53%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PureTech Health PLC (PRTC) PureTech Health PLC (PRTC) Notizie

PRTC

PureTech Health (PRTC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTC
DataOraFonteTitoloSimboloCompagnia
13/06/202422:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
13/06/202419:15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202422:39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202418:38Business WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
30/05/202414:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
29/05/202414:09Business WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
23/05/202413:00Business WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
21/05/202413:05Business WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
20/05/202413:03Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
20/05/202408:00Business WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
09/05/202413:05Business WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
07/05/202413:05Business WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
25/04/202411:22Business WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
18/04/202408:00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
16/04/202413:00Business WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
11/04/202413:00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
09/04/202408:00Business WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
19/03/202408:00Business WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
18/03/202414:52Business WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
13/03/202412:00Business WirePureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
27/02/202413:00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
27/02/202408:00Business WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:PRTCPureTech Health PLC
03/01/202413:00Business WirePureTech to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
22/12/202315:13Business WirePureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 BillionNASDAQ:PRTCPureTech Health PLC
20/12/202308:00Business WirePureTech Year End Update and Outlook for 2024NASDAQ:PRTCPureTech Health PLC
07/12/202312:00Business WirePureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023NASDAQ:PRTCPureTech Health PLC
29/11/202316:17Business WirePureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of SchizophreniaNASDAQ:PRTCPureTech Health PLC
17/11/202308:00Business WirePureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNASDAQ:PRTCPureTech Health PLC
14/11/202308:00Business WirePureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersNASDAQ:PRTCPureTech Health PLC
11/10/202313:00Business WirePureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual MeetingNASDAQ:PRTCPureTech Health PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTC

La tua Cronologia

USOTC
TKGBY
Turkiye Garanti Bankasi AS (QX)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network